Vortioxetine Hydrobromide Orally Disintegrating Tablets(Shijiazhuang Kangli Pharma)

氢溴酸伏硫西汀口崩片(石家庄康力药业)

Report date: 2026/05/27 13:47:49

Base Information

Drug NameVortioxetine Hydrobromide Orally Disintegrating Tablets(Shijiazhuang Kangli Pharma)
Drug Alias Name氢溴酸伏硫西汀口崩片(2.2改良型)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1d (5-HT1d) receptor antagonistsSerotonin 1b (5-HT1b) receptor agonistsSerotonin transporter inhibitors +[6] 
TargetsSerotonin 7 (5-HT7) receptorSerotonin 1b (5-HT1b) receptorSerotonin 1a (5-HT1a) receptor +[6] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesShijiazhuang Kangli Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShijiazhuang Kangli Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG